Matched Signals
No stored keyword or signal matches were recorded for this activity window.
Correspondence Activity Detail
Spyre Therapeutics, Inc. (SYRE)
Activity window: Sep. 25, 2025 to Sep. 24, 2026
Filings In This Window
| Date | Form | Sentiment | Urgency | Summary | Open |
|---|---|---|---|---|---|
| Feb. 25, 2026 | UPLOAD | Neutral/Informational | Low | The SEC has communicated to Spyre Therapeutics, Inc. that it will not review their registration statement filed on February 19, 2026. The letter emphasizes that the company and it… | Read Filing EDGAR |
| Feb. 25, 2026 | CORRESP | Neutral/Informational | Moderate | Spyre Therapeutics, Inc. has submitted a request to the SEC for the acceleration of its Registration Statement on Form S-3, seeking to have it declared effective by February 27, 2… | Read Filing EDGAR |
Notable 8-Ks In This Window
No notable 8-Ks were stored for this company in this activity window.